Download Files:
Products Details
Product Description
– Influenza virus-IN-8 (compound A4) is an inhibitor of influenza virus (Influenza Virus) that induces viral nucleoprotein (NP) aggregation and prevents its nuclear accumulation. Influenza virus-IN-8 has broad-spectrum anti-influenza activity and can inhibit the replication and transcription of influenza A virus. Influenza virus-IN-8 also inhibits Oseltamivir (HY-13317)-resistant H1N1/pdm09 strains[1].
Web ID
– HY-155476
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C21H16BrN5O
References
– [1]Li P et al. Identification of the Imidazo [1, 2-a] pyrazine Derivative A4 as a Potential Influenza Virus Nucleoprotein Inhibitor[J]. ACS Pharmacology & Translational Science, 2023.
CAS Number
– 1627115-50-7
Molecular Weight
– 434.29
SMILES
– BrC1=CC(C)=C(OC2=NC(NC3=CC=C(C#N)C=C3)=CN4C2=NC=C4)C(C)=C1
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
